NEOFORDEX

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug NEOFORDEX contains one active pharmaceutical ingredient (API):

1	Dexamethasone UNII E2287TKU04 - DEXAMETHASONE ACETATE, UNSPECIFIED FORM
	Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.
	Read more about Dexamethasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NEOFORDEX Tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB02	Dexamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1713855
FI	Lääkealan turvallisuus- ja kehittämiskeskus	076763
FR	Base de données publique des médicaments	68572869
IT	Agenzia del Farmaco	044832018
LT	Valstybinė vaistų kontrolės tarnyba	1079873
PL	Rejestru Produktów Leczniczych	100387800